Periscope Capital’s ProKidney PROK Stock Holding History

Periscope Capital’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-359,781	Closed	-$3.6M	–	1154
2022 Q2	$3.6M	Hold	359,781	–	–	0.1%	418
2022 Q1	$3.56M	Hold	359,781	–	–	0.09%	433
2021 Q4	$3.56M	Sell	359,781 -200	-0.1%	-$1.98K	0.1%	398
2021 Q3	$3.53M	Buy	359,981 +109,981	+44%	+$1.08M	0.1%	352
2021 Q2	$2.53M	Buy	+250,000	New	+$2.53M	0.08%	403

Other funds holding PROK

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Periscope Capital's PROK Position: Q3 2022 in Review

Periscope Capital sold out of ProKidney (PROK) in Q3 2022, closing a stake of 359,781 shares — an estimated $3.6M sold.

Periscope Capital first reported a position in PROK in Q2 2021 and held it in 5 quarters. The position peaked at $3.6M in Q2 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

Periscope Capital reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
Periscope Capital sold 359,781 ProKidney shares in Q3 2022, an estimated $3.6M.
Periscope Capital first reported a position in ProKidney in Q2 2021 and held it in 5 quarters.
Periscope Capital's ProKidney position peaked at $3.6M in Q2 2022.
18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on Periscope Capital's 13F filing for Q3 2022, filed 8 Nov 2022.